What is the appropriate ivermectin dosing regimen (200 µg/kg oral dose repeated after one week) for scabies in adults and children ≥15 kg on chronic hemodialysis and for their close contacts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ivermectin Dosing for Scabies in Hemodialysis Patients and Contacts

Dosage Regimen

For adults and children ≥15 kg on chronic hemodialysis with scabies, administer ivermectin 200 µg/kg orally with food, repeated after 14 days, with no dose adjustment required for renal impairment. 1

  • The standard dose is 200 µg/kg (for example, a 56-kg patient receives 12 mg total as four 3-mg tablets) given as a single dose on day 1, then repeated on day 15. 1
  • No dosage adjustments are necessary for patients with renal impairment, including those on hemodialysis. 1, 2
  • Ivermectin must be taken with food to increase bioavailability and enhance drug penetration into the epidermis. 1, 3, 2

Treatment Scheme Timeline

Day 1: First dose of ivermectin 200 µg/kg with food 1

Day 14-15: Second mandatory dose of ivermectin 200 µg/kg with food 1, 4

  • The 2-week repeat dose is mandatory because ivermectin has limited ovicidal activity and does not kill all stages of the mite life cycle. 1, 4
  • A second dose given 7-10 days after the first substantially improves cure rates. 4

Contact Management

All household members, close contacts, and sexual partners within the previous month must be treated simultaneously with the same regimen, even if asymptomatic. 1, 3, 2

  • Contacts should receive ivermectin 200 µg/kg on day 1 and day 14-15, identical to the index patient. 1
  • Failure to treat asymptomatic contacts simultaneously is a frequent cause of reinfection and treatment failure. 3
  • This simultaneous treatment prevents the cycle of reinfection between the patient and their contacts. 3, 2

Pediatric Considerations for Contacts

Children weighing <15 kg or under 10 years old should NOT receive ivermectin due to potential neurotoxicity from blood-brain barrier penetration. 1, 3, 2

  • For pediatric contacts <15 kg, use permethrin 5% cream instead, applied from neck down (or entire body including scalp if <2 years), left on 8-14 hours, then washed off. 3
  • Recent research suggests ivermectin may be safe in children 2-4 years weighing 10-14 kg at a 3 mg dose, but this remains off-label and guidelines still recommend permethrin for this age group. 5, 6

Post-Treatment Expectations

Pruritus and rash may persist for up to 2 weeks after successful treatment due to allergic dermatitis, not treatment failure. 1, 3, 2

  • Topical corticosteroids and oral antihistamines can relieve persistent itching during this period. 1
  • Retreatment should only be considered after 2 weeks if live mites are observed or symptoms persist beyond 2 weeks. 3, 2
  • Premature retreatment within the first 2 weeks based solely on persistent itching should be avoided. 3

Environmental Decontamination

Machine-wash and dry all bedding, clothing, and towels using hot cycles, or isolate items from skin contact for at least 72 hours. 3, 2

  • Scabies mites cannot survive off the human host for longer than 72 hours. 3
  • Fumigation of living areas is not required for scabies eradication. 3, 2

Critical Pitfalls to Avoid

Forgetting the second dose on day 14-15 is the most common error, as single-dose therapy has substantially lower cure rates. 1, 4

Not treating all contacts simultaneously leads to reinfection cycles and apparent treatment failure. 1, 3

Taking ivermectin without food markedly reduces absorption and treatment efficacy. 1, 3

Using ivermectin in children <15 kg or <10 years risks neurotoxicity; permethrin is the appropriate alternative for this population. 1, 3, 2

References

Guideline

Ivermectin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Scabies Management in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Review of ivermectin in scabies.

Journal of cutaneous medicine and surgery, 2001

Related Questions

What is the recommended oral ivermectin dose for treating scabies in children, including the weight (≥15 kg) and age (≈≥5 years) criteria, and what alternative therapy should be used for younger or lighter children?
What is the minimum age to administer ivermectin to a child?
Can pediatric patients receive oral ivermectin?
What is the appropriate way to prescribe ivermectin tablets for a child, including indication, weight‑based dosing, and formulation?
What is the appropriate oral ivermectin dose for a 6‑month‑old infant weighing about 7 kg?
In a patient with chronic heart failure who presents with hypernatremia (serum sodium ≈150 mEq/L) and hypovolemia (hypotension, orthostatic changes, dry mucous membranes, reduced skin turgor, weight loss, low central venous pressure), how should the hypernatremia be managed?
What immediate‑release diltiazem dose regimen is equivalent to a 120 mg once‑daily extended‑release (non‑XR) tablet?
What evidence supports trying an antidepressant at its minimum effective dose for at least four to six weeks before concluding it is ineffective?
How can I safely switch a patient taking alprazolam 0.5 mg three times daily (total 1.5 mg per day) to a longer‑acting benzodiazepine and taper the regimen?
What is the appropriate management for an elderly, frail nursing‑home resident with a chronic, irreducible rectal prolapse causing pain (but with normal bowel movements) newly admitted from the hospital?
What are the treatment options for progressive multiple sclerosis (primary‑progressive and secondary‑progressive)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.